Purchases and Sales Made in Q4 2023 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q4 2023. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2024
Q4 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-269K- 46.02% |
$28.5M - $35.7M
|
316K
$42.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-313K- 25.87% |
$33.2M - $41.6M
|
897K
$120M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-624K- 84.79% |
$66.2M - $82.9M
|
112K
$15M
|
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.19M- 46.01% |
$126M - $157M
|
1.39M
$186M
|